Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation

por Odnopozova, Liudmila, Edin, Anton, Sukharev, Alexey, Wu, Tianshuang, Aydin, Kerstin, Kelly, Maureen, Khotko, Alkes
Publicado 2022

Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials

por Sticherling, Michael, Nikkels, Arjen F., Hamza, Ashraf M., Kwong, Pearl, Szepietowski, Jacek C., El Sayed, Mahira, Ghislain, Pierre-Dominique, Khotko, Alkes A., Patekar, Manmath, Ortmann, Christine-Elke, Forrer, Pascal, Papanastasiou, Philemon, Keefe, Deborah
Publicado 2023

Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial

por Samtsov, Alexey V., Bakulev, Andrey L., Khairutdinov, Vladislav R., Kokhan, Muza M., Korotaeva, Tat’yana V., Minullin, Iskander K., Vylegzhanina, Olga A., Dubenskiy, Valery V., Khalilov, Bulat V., Khotko, Alkes A., Zykova, Olga S., Chumachenko, Irina V., Lukyanov, Alexander M., Artemeva, Antonina V., Pukhtinskaia, Polina P.
Publicado 2022